(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
NCCN Guidelines for Patients for CLL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN COVID-19 Resources Page
Cancer.gov